Ophthalmic Drug Market in China Attracts Increasing Attention

As ophthalmic diseases become more prevalent in China, there is a growing demand for high-quality and affordable eye medicines. It is expected that the market size for ophthalmic drugs in China will reach about 25 billion RMB in 2021.
by Yinpeng Feng Mar 22, 2021

In early March, during China's 2021 Two Sessions (annual meetings of the National People's Congress (NPC) and the National Committee of the Chinese People's Political Consultative Conference (CPPCC)), health care was one of the hotly discussed topics. Professor Wang Ningli, a representative of the CPPCC and also an influential ophthalmologist, pointed out that eye health is an essential component of the overall health condition, and the central government should further explore options that could help improve eye health, provide high quality eye treatment for patients, and eventually decrease the number of people suffering from vision impairment or loss in China.1

Yinpeng Feng
ChemLinked Regulatory Analyst
Copyright: unless otherwise stated all contents of this website are ©2021 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com